Researchers at Johns Hopkins have coaxed stem cells into forming networks of new blood vessels in the laboratory, then successfully transplanted them into mice.
Shown are lab-grown human blood vessel networks (red) incorporating into and around mouse networks (green). Credit: PNAS
The stem cells are made by reprogramming ordinary cells, so the new technique could potentially be used to make blood vessels genetically matched to individual patients and unlikely to be rejected by their immune systems, the investigators say. The results appear online this week in the Proceedings of the National Academy of Sciences.
"In demonstrating the ability to rebuild a microvascular bed in a clinically relevant manner, we have made an important step toward the construction of blood vessels for therapeutic use," says Sharon Gerecht, Ph.D., an associate professor in the Johns Hopkins University Department of Chemical and Biomolecular Engineering, Physical Sciences–Oncology Center and Institute for NanoBioTechnology. "Our findings could yield more effective treatments for patients afflicted with burns, diabetic complications and other conditions in which vasculature function is compromised."
Gerecht's research group and others had previously grown blood vessels in the laboratory using stem cells, but barriers remain to efficiently producing the vessels and using them to treat patients.
For the current study, the group focused on streamlining the new growth process. Where other experiments used chemical cues to get stem cells to form cells of a single type, or to mature into a smorgasbord of cell types that the researchers would then sort through, graduate student Sravanti Kusuma devised a way to get the stem cells to form the two cell types needed to build new blood vessels — and only those types. "It makes the process quicker and more robust if you don't have to sort through a lot of cells you don't need to find the ones you do, or grow two batches of cells," she says.
A second difference from previous experiments was that instead of using adult stem cells derived from cord blood or bone marrow to construct the network of vessels, Gerecht's group teamed with Linzhao Cheng, Ph.D., a professor in the Institute for Cell Engineering, to use induced pluripotent stem cells as their starting point. Since this type of cell is made by reverse-engineering mature cells — from the skin or blood, for example — using it means that the resulting blood vessels could be tailor-made for specific patients, Kusuma says. "This is an elegant use of human induced pluripotent stem cells that can form multiple cell types within one kind of tissue or organ and have the same genetic background," Cheng says. "This study showed that in addition to being able to form blood cells and neural cells as previously shown, blood-derived human induced pluripotent stem cells can also form multiple types of vascular network cells."
To grow the vessels, the research team put the stem cells into a scaffolding made of a squishy material called hydrogel. The hydrogel was loaded with chemical cues that nudged the cells to organize into a network of recognizable blood vessels made up of cells that create the network and the type that support and give vessels their structure. This was the first time that blood vessels had been constructed from human pluripotent stem cells in synthetic material.
To learn whether the vessel-infused hydrogel would work inside a living animal, the group implanted it into mice. After two weeks, the lab-grown vessels had integrated with the mice's own vessels, and the hydrogel had begun to biodegrade and disappear as it had been designed to do. "That these vessels survive and function inside a living animal is a crucial step in getting them to medical application," Kusuma says.
One of the next steps, she says, will be to look more closely at the 3-D structures the lab-grown vessels form. Another will be to see whether the vessels can deliver blood to damaged tissues and help them recover.
The study was funded by the American Heart Association, the National Heart, Lung, and Blood Institute (grant numbers F31HL112644, 2R01 HL073781 and R01 HL107938), the National Cancer Institute (grant number U54CA143868) and the National Science Foundation (grant number 1054415).
Other authors on the report were Yu-I Shen, Donny Hanjaya-Putra and Prashant Mali, all of The Johns Hopkins University.
Link to the PNAS article: http://www.pnas.org/content/early/2013/07/10/1306562110.abstract?sid=90ae5bc4-5a8e-41ec-be25-ec2c25923f9a
Steering Stem Cells to Become Two Different Building Blocks for New Blood Vessels: http://releases.jhu.edu/2012/12/20/steering-stem-cells-to-become-building-blocks-for-blood-vessels/
Researcher Seeks to Turn Stem Cells into Blood Vessels: http://www.jhu.edu/news/home09/feb09/gerecht.htmlLinzhao Cheng on Making Stem Cells from a Patient's Blood Sample: http://www.hopkinsmedicine.org/institute_cell_engineering/_includes/videos/
Shawna Williams | EurekAlert!
Further reports about: > 3-D structure > Stem cell innovation > adult stem cell > blood cell > blood flow > blood vessel > cell type > effective treatment > immune system > induced pluripotent stem > induced pluripotent stem cell > methanol fuel cells > new blood vessels > pluripotent stem > pluripotent stem cells > stem cells
Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy